These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 3013096)
21. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349 [TBL] [Abstract][Full Text] [Related]
22. Diagnostic significance of platelet count and other blood analyses in patients with lung cancer. Pedersen LM; Milman N Oncol Rep; 2003; 10(1):213-6. PubMed ID: 12469171 [TBL] [Abstract][Full Text] [Related]
23. NTP Toxicology and Carcinogenesis Studies of D&C Yellow No. 11 (CAS No. 8003-22-3) in F344/N Rats (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1997 Apr; 463():1-190. PubMed ID: 12587013 [TBL] [Abstract][Full Text] [Related]
24. NTP Toxicology and Carcinogenesis Studies of Isobutyl Nitrite (CAS No. 542-56-3) in F344 Rats and B6C3F1 Mice (Inhalation Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Jul; 448():1-302. PubMed ID: 12594527 [TBL] [Abstract][Full Text] [Related]
25. Outcomes of patients with hepatocellular carcinoma presenting with variceal bleeding. Lang BH; Poon RT; Fan ST; Wong J Am J Gastroenterol; 2004 Nov; 99(11):2158-65. PubMed ID: 15554997 [TBL] [Abstract][Full Text] [Related]
26. NTP Toxicology and Carcinogenesis Studies of Gallium Arsenide (CAS No. 1303-00-0) in F344/N Rats and B6C3F1 Mice (Inhalation Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2000 Sep; 492():1-306. PubMed ID: 12563348 [TBL] [Abstract][Full Text] [Related]
27. Clinical significance and prediction factors of gastric varices in patients with hepatocellular carcinoma. Yeh JL; Peng YC; Tung CF; Yang DY; Hu WH; Chow WK; Yeh HZ; Chen GH Hepatogastroenterology; 2003; 50(53):1603-8. PubMed ID: 14571795 [TBL] [Abstract][Full Text] [Related]
28. Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver. Chang CH; Chau GY; Lui WY; Tsay SH; King KL; Wu CW Arch Surg; 2004 Mar; 139(3):320-5; discussion 326. PubMed ID: 15006892 [TBL] [Abstract][Full Text] [Related]
29. Clinical and morphological study of hepatocellular carcinoma associated with liver cirrhosis. Antón MD; Serra MA; Del Olmo J; Rodrigo JM Rev Esp Enferm Dig; 1997 Aug; 89(8):599-610. PubMed ID: 9299919 [TBL] [Abstract][Full Text] [Related]
30. Long course and prognostic factors of virus-induced cirrhosis of the liver. Gentilini P; Laffi G; La Villa G; Romanelli RG; Buzzelli G; Casini-Raggi V; Melani L; Mazzanti R; Riccardi D; Pinzani M; Zignego AL Am J Gastroenterol; 1997 Jan; 92(1):66-72. PubMed ID: 8995940 [TBL] [Abstract][Full Text] [Related]
31. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295 [TBL] [Abstract][Full Text] [Related]
32. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related]
33. NTP Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344 Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Nov; 446():1-317. PubMed ID: 12594529 [TBL] [Abstract][Full Text] [Related]
34. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma. Lu SN; Wang JH; Liu SL; Hung CH; Chen CH; Tung HD; Chen TM; Huang WS; Lee CM; Chen CC; Changchien CS Cancer; 2006 Nov; 107(9):2212-22. PubMed ID: 17019738 [TBL] [Abstract][Full Text] [Related]
35. Serum cathepsin B and plasma urokinase-type plasminogen activator levels in gastrointestinal tract cancers. Herszényi L; István G; Cardin R; De Paoli M; Plebani M; Tulassay Z; Farinati F Eur J Cancer Prev; 2008 Oct; 17(5):438-45. PubMed ID: 18714186 [TBL] [Abstract][Full Text] [Related]
36. Overt iron deficiency in sickle cell disease. Haddy TB; Castro O Arch Intern Med; 1982 Sep; 142(9):1621-4. PubMed ID: 7114979 [TBL] [Abstract][Full Text] [Related]
37. Peripheral blood and bone marrow changes in patients with acquired immunodeficiency syndrome. Adediran IA; Durosinmi MA Afr J Med Med Sci; 2006 Dec; 35 Suppl():85-91. PubMed ID: 18050779 [TBL] [Abstract][Full Text] [Related]
38. Causes of anemia in renal transplant recipients. Karakuş S; Kanbay M; Köseoğlu HK; Colak T; Haberal M Transplant Proc; 2004; 36(1):164-5. PubMed ID: 15013334 [TBL] [Abstract][Full Text] [Related]